XML 97 R111.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation (Stock Option Valuation Assumptions) (Details)
12 Months Ended
Dec. 31, 2018
$ / shares
Dec. 31, 2017
AmpliPhi Biosciences Corporation [Member]    
Expected volatility, minimum   117.00%
Common stock closing price $ 0.21  
AmpliPhi Biosciences Corporation [Member] | Restricted Stock [Member]    
Risk-free interest rate, maximum 2.99% 2.36%
Risk-free interest rate, minimum 2.74% 1.27%
Expected volatility, maximum 126.00% 144.00%
Expected volatility, minimum 121.00%  
Expected term (in years) 6 years 7 days  
Expected dividend yield 0.00% 0.00%
Measurement Input, Expected Dividend Rate [Member] | C3J [Member]    
Equity Securities, FV-NI, Measurement Input   0
Measurement Input, Expected Term [Member] | C3J [Member]    
Equity Securities, FV-NI, Measurement Input   6.25
Measurement Input, Price Volatility [Member] | C3J [Member]    
Equity Securities, FV-NI, Measurement Input   106
Measurement Input, Risk Free Interest Rate [Member] | C3J [Member]    
Equity Securities, FV-NI, Measurement Input   1.97
Minimum [Member] | AmpliPhi Biosciences Corporation [Member] | Restricted Stock [Member]    
Expected term (in years)   2 years
Maximum [Member] | AmpliPhi Biosciences Corporation [Member] | Restricted Stock [Member]    
Expected term (in years)   9 years 1 month 6 days